Imaging clinics and third-party reporting are increasingly interwoven: scans are acquired in clinics and interpreted around the clock via teleradiology.

AI will matter most where specificity can safely triage high volumes (e.g., screening) and in writing first-draft reports.

For point of care-devices, hospitals increasingly demand integrating with their EPR systems.

There is a whole new category of monitoring devices aimed at consumers, who are keen to export the data to their care givers (who are less keen to handle the data, as they are unsure of its clinical utility).

We support investors and operators across imaging networks, teleradiology, IVD and remote/device-enabled monitoring. Our work includes commercial due diligence, portfolio reviews and growth strategy. We test adoption drivers by indication and care setting, benchmark contracting and pricing, and model “hybrid” offers that bundle capital-light services with data/AI. Where relevant, we assess the case for integrating reporting with clinic operations to capture pathway economics and defend margins.

In the UK and Europe, structure shapes outcomes. The UK’s relatively open reporting market and standard frameworks have supported a sizeable teleradiology sector and enabled clinic–reporting models to scale; community imaging capacity adds opportunity but requires realistic assumptions on staffing, case-mix and contracting. Our perspective blends on-the-ground clinic economics with reporting workflows and AI readiness, so growth plans reflect demand and delivery reality—not just headline forecasts.